Pegfilgrastim
From Wikipedia, the free encyclopedia
|
Pegfilgrastim
|
|
| Systematic (IUPAC) name | |
| PEGylated human granulocyte colony stimulating factor | |
| Identifiers | |
| CAS number | |
| ATC code | L03 |
| PubChem | ? |
| DrugBank | |
| Chemical data | |
| Formula | C845H1343N223O243S9 |
| Mol. mass | 18802.8 g/mol |
| Pharmacokinetic data | |
| Bioavailability | ? |
| Metabolism | ? |
| Half life | 15-80 hrs |
| Excretion | ? |
| Therapeutic considerations | |
| Pregnancy cat. |
? |
| Legal status | |
| Routes | ? |
Pegfilgrastim is a immunostimulator which functions as a PEGylated granulocyte colony-stimulating factor. Amgen manufactures pegfilgrastim under the brand name Neulasta.
|
|||||||||||||||||

